Subscribe To

Price Alert Latest News Economic Calendar News

HPGSF / Hipgnosis would-be rival bidders say music rights are too expensive

Hipgnosis Songs Fund Limited (LSE:SONG) said it received a lukewarm reception for its tranche of music rights after shopping it around with would-be buyers saying they weren't prepared to match a $440 million offer already on the table from Blackstone. In all, 17 groups were contacted as part of the 'Go-Shop' process, with eight eventually signing non-disclosure agreements. Read More

Demo Live Account See Partner Details

Content Topics

Hipgnosis

Would

Be

Rival

Bidders

Music

Rights

Expensive

Would be

Stock

HPGSF

Posted: Oct 24 2023, 03:02

Author Name: Proactive Investors

HPGSF News

By Proactive Investors
October 27, 2023

Hipgnosis Songs Fund: investors and analysts wait for answers after failed continuation vote

The failure of Hipgnosis Songs Fund's (LSE:SONG) continuation vote raises many questions for investors, though some investment bank analysts said it

By Proactive Investors
October 26, 2023

Hipgnosis Songs shareholders vote against continuation, chairman given boot

Hipgnosis Songs Fund Limited (LSE:SONG) shareholders chose 'no' in a continuation vote and for the investment trust's chairman to go. A total of 83.2

By Proactive Investors
October 24, 2023

Hipgnosis would-be rival bidders say music rights are too expensive

Hipgnosis Songs Fund Limited (LSE:SONG) said it received a lukewarm reception for its tranche of music rights after shopping it around with would-be b

By Proactive Investors
October 20, 2023

Hipgnosis Songs shareholder calls for 'clean break' and removal of three directors

Hipgnosis Songs Fund Limited (LSE:SONG) shareholder Metage Capital has written a letter to other investors that recommends voting against three curr

By Proactive Investors
October 19, 2023

Hipgnosis Songs relationships 'breaking down', say analysts

The board of Hipgnosis Songs Fund (LSE:SONG) launching a strategic review today, including a potential break-up with founder Merck Mercuriadis' mana

By Proactive Investors
October 19, 2023

Hipgnosis Songs Fund launches strategic review

It looks like all options are on the table at the beleaguered Hipgnosis Songs Fund Limited (LSE:SONG) after it launched a strategic review. With that

By Proactive Investors
October 17, 2023

Hipgnosis Songs Fund meeting to face objections from major shareholders

Analysts and a major investor say that the upcoming Hipgnosis Songs Fund Limited (LSE:SONG) shareholder meeting might echo the Ella Fitzgerald song

By Proactive Investors
September 29, 2023

Hipgnosis Songs deal tweaks are 'helpful' but manager change is 'optimal solution'

Changes that Hipgnosis Songs Fund Limited (LSE:SONG) proposed to smooth shareholder acceptance of its proposed music rights sale to Blackstone are "

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.